Bain Capital Life Sciences Investors, LLC Cara Therapeutics, Inc. Transaction History

Bain Capital Life Sciences Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.83 - $4.94 $3.59 Million - $6.27 Million	-1,269,551 Reduced 57.59%	934,898 $2.65 Million
Q1 2023 May 15, 2023	SELL	$4.89 - $12.27 $2.4 Million - $6.03 Million	-491,581 Reduced 18.23%	2,204,449 $10.8 Million
Q4 2022 Feb 14, 2023	BUY	$8.88 - $12.77 $431,186 - $620,072	48,557 Added 1.83%	2,696,030 $29 Million
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $19.7 Million - $36.6 Million	2,647,473 New	2,647,473 $24.2 Million

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.